Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)
Clinical trial NCT01193907 · COMPLETED
Trial details
- NCT number
- NCT01193907
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2010-11-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.